NO20011217D0 - Doseringsform omfattende væskeformulering - Google Patents

Doseringsform omfattende væskeformulering

Info

Publication number
NO20011217D0
NO20011217D0 NO20011217A NO20011217A NO20011217D0 NO 20011217 D0 NO20011217 D0 NO 20011217D0 NO 20011217 A NO20011217 A NO 20011217A NO 20011217 A NO20011217 A NO 20011217A NO 20011217 D0 NO20011217 D0 NO 20011217D0
Authority
NO
Norway
Prior art keywords
dosage form
liquid formulation
emulsifies
self
disclosed
Prior art date
Application number
NO20011217A
Other languages
English (en)
Other versions
NO20011217L (no
Inventor
Liang C Dong
Patrick S-L Wong
Steven D Espinal
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of NO20011217D0 publication Critical patent/NO20011217D0/no
Publication of NO20011217L publication Critical patent/NO20011217L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20011217A 1998-09-09 2001-03-09 Doseringsform omfattende v¶skeformulering NO20011217L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9961998P 1998-09-09 1998-09-09
PCT/US1999/020332 WO2000013663A1 (en) 1998-09-09 1999-09-03 Dosage form comprising liquid formulation

Publications (2)

Publication Number Publication Date
NO20011217D0 true NO20011217D0 (no) 2001-03-09
NO20011217L NO20011217L (no) 2001-05-08

Family

ID=22275865

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011217A NO20011217L (no) 1998-09-09 2001-03-09 Doseringsform omfattende v¶skeformulering

Country Status (19)

Country Link
EP (1) EP1112060B1 (no)
JP (1) JP2002524407A (no)
KR (1) KR100620292B1 (no)
CN (1) CN1227003C (no)
AT (1) ATE311858T1 (no)
AU (1) AU751086B2 (no)
CA (1) CA2341297C (no)
CY (1) CY1105465T1 (no)
DE (1) DE69928815T2 (no)
DK (1) DK1112060T3 (no)
ES (1) ES2251840T3 (no)
HK (1) HK1038508B (no)
HU (1) HU226669B1 (no)
IL (2) IL141914A0 (no)
NO (1) NO20011217L (no)
NZ (1) NZ510020A (no)
RU (1) RU2227021C2 (no)
WO (1) WO2000013663A1 (no)
ZA (1) ZA200101994B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL164163A0 (en) * 2002-04-09 2005-12-18 Pharmacia Corp Process for preparing a finely self-emulsifiable pharmaceutical composition
EP1556017A1 (en) * 2002-10-31 2005-07-27 ALZA Corporation Dosage form providing ascending release of liquid formulation
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
WO2007083323A2 (en) * 2006-01-23 2007-07-26 Panacea Biotec Limited. Modified release oral dosage form comprising desmopressin
EP2020990B1 (en) 2006-05-30 2010-09-22 Intarcia Therapeutics, Inc Two-piece, internal-channel osmotic delivery system flow modulator
AU2007284759B2 (en) 2006-08-09 2010-10-28 Intarcia Therapeutics, Inc. Osmotic delivery systems and piston assemblies
AU2008244523B2 (en) 2007-04-23 2012-02-16 Intarcia Therapeutics, Inc. Suspension formulations of insulinotropic peptides and uses thereof
EP2240155B1 (en) 2008-02-13 2012-06-06 Intarcia Therapeutics, Inc Devices, formulations, and methods for delivery of multiple beneficial agents
RU2547990C2 (ru) 2009-09-28 2015-04-10 Интарсия Терапьютикс, Инк. Быстрое достижение и/или прекращение существенной стабильной доставки лекарственного средства
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
CN103933017A (zh) * 2014-03-26 2014-07-23 邵娜 一种***缓释胶囊
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
EP3302354B1 (en) 2015-06-03 2023-10-04 i2o Therapeutics, Inc. Implant placement systems
RU2760007C2 (ru) 2016-05-16 2021-11-22 Интарсия Терапьютикс, Инк. Полипептиды, селективные к рецепторам глюкагона, и способы их применения
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
WO2018129058A1 (en) 2017-01-03 2018-07-12 Intarcia Therapeutics, Inc. Methods comprising continuous administration of a glp-1 receptor agonist and co-adminstration of a drug
CN115490316B (zh) * 2022-01-24 2023-09-12 成都理工大学 一种可再利用的地下水营养物质缓释胶囊体

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH580961A5 (en) * 1972-01-13 1976-10-29 Alza Corp Dispenser - functioning by osmotic pressure using active agents in solid or semi solid form
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
AU591171B2 (en) * 1983-11-02 1989-11-30 Alza Corporation Dispenser for delivering thermo-responsive composition
GB2155889B (en) * 1984-03-21 1988-03-02 Alza Corp Dispenser-capsule
US4842867A (en) * 1986-05-09 1989-06-27 Alza Corporation Pulsed drug delivery of doxylamine
US5324280A (en) * 1990-04-02 1994-06-28 Alza Corporation Osmotic dosage system for delivering a formulation comprising liquid carrier and drug
EP0716595B1 (en) * 1993-08-31 1998-11-25 Alza Corporation Dispenser containing hydrophobic agent
ZA953078B (en) * 1994-04-28 1996-01-05 Alza Corp Effective therapy for epilepsies
DK0768867T3 (da) * 1994-06-13 2002-10-28 Alza Corp Doseringsform til indgivelse af lægemiddel i væskeformig formulering
US5633011A (en) * 1994-08-04 1997-05-27 Alza Corporation Progesterone replacement therapy
US5904935A (en) * 1995-06-07 1999-05-18 Alza Corporation Peptide/protein suspending formulations

Also Published As

Publication number Publication date
ES2251840T3 (es) 2006-05-01
ATE311858T1 (de) 2005-12-15
WO2000013663A1 (en) 2000-03-16
HU226669B1 (en) 2009-06-29
HUP0104034A3 (en) 2002-12-28
KR20010086394A (ko) 2001-09-10
DE69928815T2 (de) 2006-06-29
AU751086B2 (en) 2002-08-08
DE69928815D1 (de) 2006-01-12
EP1112060B1 (en) 2005-12-07
EP1112060A1 (en) 2001-07-04
CN1316897A (zh) 2001-10-10
HUP0104034A2 (hu) 2002-04-29
CA2341297C (en) 2009-02-24
CN1227003C (zh) 2005-11-16
NZ510020A (en) 2003-06-30
IL141914A (en) 2008-06-05
JP2002524407A (ja) 2002-08-06
RU2227021C2 (ru) 2004-04-20
ZA200101994B (en) 2002-03-11
AU5705199A (en) 2000-03-27
DK1112060T3 (da) 2006-04-18
IL141914A0 (en) 2002-03-10
HK1038508B (zh) 2006-06-30
KR100620292B1 (ko) 2006-09-13
CY1105465T1 (el) 2010-04-28
NO20011217L (no) 2001-05-08
CA2341297A1 (en) 2000-03-16
HK1038508A1 (en) 2002-03-22

Similar Documents

Publication Publication Date Title
NO20011217D0 (no) Doseringsform omfattende væskeformulering
ATE312602T1 (de) Orale pharmazeutische dosierungsform mit verlängerter wirkstofffreisetzung
NO20022998D0 (no) Farmasöytiske preparater som tilveiebringer foröket konsentrasjon av medikament
DE69525148T2 (de) Pharmazeutische formulierung
DE69928085D1 (de) Dosierungsform mit verlängerter wirkstoffabgabe
NO20030627D0 (no) Hydrogel-drevet medikament doseringsform
EE04002B1 (et) Peroraalne farmatseutiline annusvorm, mis sisaldab prootonpumba inhibiitorit ja antatsiidainet või alginaati
DK1208864T3 (da) Forbedringer til lægemiddelafgivelsesindretninger
EE04003B1 (et) Peroraalne farmatseutiline annusvorm, mis sisaldab prootonpumba inhibiitorit ja NSAID
ID24654A (id) Formulasi farmasi omeprazola
DE69923076D1 (de) Transthorakale arzneimittelabgabevorrichtung
ITTO20010005A1 (it) Formulazione farmaceutica.
ID22565A (id) Penggunaan nanodispersi dalam formulasi akhir obat
BR9607851B1 (pt) combinaÇço e formulaÇço farmacÊutica.
ATE292453T1 (de) Antivirale arznei
PT768867E (pt) Forma de dosagem para a administracao de droga em formulacao liquida
ATE429224T1 (de) Arzneizubereitungen enthaltend mindestens einen hiv preoteaseinhibitor
EE05415B1 (et) Ravimi manustamise vahend, eriti androgeenide manustamiseks
ID30032A (id) Formulasi farmasi
DE19681529D2 (de) Pharmazeutische Darreichungsform
PT1014951E (pt) Composicao de revestimento farmaceutica e metodo para a sua utilizacao
DK1054666T3 (da) Væskeformig farmaceutisk formulering, der indeholder zotepin
SE9803271D0 (sv) A drug for well-being
SE9803952D0 (sv) Pharmaceutical formulation
DE69938347D1 (de) Medikamentöse verabreichung von nikotin in form von kaugummi

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application